By introduction. Capacity is limited.

We do not solicit, advertise, or pursue commercial interest at scale. The institutions Synnytra serves arrive through trusted referral, regulatory introduction, or peer recommendation.

This is not a constraint of growth. It is a deliberate posture. The work is technical, sensitive, and built to last — and the relationships supporting it are selected with the same care.

Synnytra engages with three categories of counterparty.

Institutional Principals

Chief Risk Officers, Chief Compliance Officers, Chief Technology Officers, and Heads of Procurement at Tier 1 financial institutions, federally regulated entities, and major pharmaceutical and life sciences enterprises.

Federal and Sovereign Counterparties

Senior procurement officials, security-cleared technical leads, and policy principals at federal departments, Crown corporations, defence agencies, and intelligence services.

Senior Counsel and Advisors

Partners at Tier 1 law firms specialising in technology, regulatory, and intellectual property matters. Senior advisors at consulting firms supporting regulated AI deployments.

Engagements proceed through a defined sequence. Each step is deliberate and the pace reflects the seriousness of the work.

• Introduction. Initial contact arrives through a trusted intermediary or peer referral. Cold inquiries are reviewed but rarely engaged.
• Mutual Non-Disclosure. Substantive conversation begins after a mutual NDA is in place. Synnytra protects its work as carefully as we expect counterparties to protect theirs.
• Capabilities Review. Detailed capabilities, architecture, and deployment posture are reviewed in confidence. Counterparties bring their use case, regulatory frame, and procurement constraints.
• Engagement Definition. If alignment is established, a defined engagement is structured — pilot, integration, advisory, or full deployment.
• Delivery. Synnytra delivers under formal agreement, with the audit posture and confidentiality standards the institutional context requires.

Clarity about what Synnytra is not is as important as clarity about what it is.

• We do not provide consumer-facing products.
• We do not pursue speculative or pre-revenue startups.
• We do not engage on matters where the counterparty is not an institutional principal.
• We do not disclose architectural detail before NDA execution.
• We do not compete on price. The work's value is determined by what it protects.